Cargando…

The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms

BACKGROUND: The index case is a 21‐year‐old Italian woman with a mild hemorrhagic syndrome and von Willebrand factor antigen (VWF:Ag) = 34.3 U/dl, VWF recombinant glycoprotein Ib (VWF:GpIbR) = 32.8 U/dl, and factor VIII (FVIII) = 55.3 IU/dl. AIMS: The aim of this study is to characterize from a gene...

Descripción completa

Detalles Bibliográficos
Autores principales: Sacco, Monica, Lancellotti, Stefano, Branchini, Alessio, Tardugno, Maira, Testa, Maria Francesca, Lunghi, Barbara, Bernardi, Francesco, Pinotti, Mirko, Giusti, Betti, Castaman, Giancarlo, De Cristofaro, Raimondo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545986/
https://www.ncbi.nlm.nih.gov/pubmed/35596664
http://dx.doi.org/10.1111/jth.15765
_version_ 1784804940011536384
author Sacco, Monica
Lancellotti, Stefano
Branchini, Alessio
Tardugno, Maira
Testa, Maria Francesca
Lunghi, Barbara
Bernardi, Francesco
Pinotti, Mirko
Giusti, Betti
Castaman, Giancarlo
De Cristofaro, Raimondo
author_facet Sacco, Monica
Lancellotti, Stefano
Branchini, Alessio
Tardugno, Maira
Testa, Maria Francesca
Lunghi, Barbara
Bernardi, Francesco
Pinotti, Mirko
Giusti, Betti
Castaman, Giancarlo
De Cristofaro, Raimondo
author_sort Sacco, Monica
collection PubMed
description BACKGROUND: The index case is a 21‐year‐old Italian woman with a mild hemorrhagic syndrome and von Willebrand factor antigen (VWF:Ag) = 34.3 U/dl, VWF recombinant glycoprotein Ib (VWF:GpIbR) = 32.8 U/dl, and factor VIII (FVIII) = 55.3 IU/dl. AIMS: The aim of this study is to characterize from a genetic and biochemical standpoint this low VWF phenotype. METHODS: Coagulation and biochemical methods were used to study the structural and functional pattern of VWF multimers in the index case’s plasma. Recombinant wild‐type and p.P1127S VWF variants were produced using human embryonic kidney (HEK)‐293 cells. In addition, genetic screening was carried out to detect single nucleotide variants of some scavenger VWF/FVIII receptor genes such as CLEC4M, STAB2, and ASGR2. RESULTS: Genetic investigation revealed that the index case inherited from her mother the heterozygous missense mutation c.3379C > T (VWF exon 25), causing the p.P1127S substitution in the VWF D′D3 domain. The index case was also homozygous for the scavenger receptor ASGR2 c.‐95 CC‐genotype. Desmopressin normalized the VWF level of the patient, although its clearance was faster (t (1/2) = 6.7 h) than in normal subjects (t (1/2) = 12 ± 0.7 h). FVIII‐VWF interaction, A Disintegrin And Metalloprotease with ThromboSpondin type 1 motif‐13 levels, ristocetin‐induced‐platelet‐aggregation, and VWF multimeric pattern were normal. The p.P1127S variant was normally synthesized and secreted by HEK‐293 cells, and molecular modeling predicts a conformational change showing higher affinity for the macrophagic scavenger receptor lipoprotein receptor‐related protein 1 (LRP1), as also experimentally verified. CONCLUSIONS: The p.P1127S variant may cause a low VWF phenotype, stemming from an increased VWF affinity for the scavenger receptor LRP1 and, consequently, an accelerated clearance of VWF.
format Online
Article
Text
id pubmed-9545986
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-95459862022-10-14 The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms Sacco, Monica Lancellotti, Stefano Branchini, Alessio Tardugno, Maira Testa, Maria Francesca Lunghi, Barbara Bernardi, Francesco Pinotti, Mirko Giusti, Betti Castaman, Giancarlo De Cristofaro, Raimondo J Thromb Haemost HAEMOSTASIS BACKGROUND: The index case is a 21‐year‐old Italian woman with a mild hemorrhagic syndrome and von Willebrand factor antigen (VWF:Ag) = 34.3 U/dl, VWF recombinant glycoprotein Ib (VWF:GpIbR) = 32.8 U/dl, and factor VIII (FVIII) = 55.3 IU/dl. AIMS: The aim of this study is to characterize from a genetic and biochemical standpoint this low VWF phenotype. METHODS: Coagulation and biochemical methods were used to study the structural and functional pattern of VWF multimers in the index case’s plasma. Recombinant wild‐type and p.P1127S VWF variants were produced using human embryonic kidney (HEK)‐293 cells. In addition, genetic screening was carried out to detect single nucleotide variants of some scavenger VWF/FVIII receptor genes such as CLEC4M, STAB2, and ASGR2. RESULTS: Genetic investigation revealed that the index case inherited from her mother the heterozygous missense mutation c.3379C > T (VWF exon 25), causing the p.P1127S substitution in the VWF D′D3 domain. The index case was also homozygous for the scavenger receptor ASGR2 c.‐95 CC‐genotype. Desmopressin normalized the VWF level of the patient, although its clearance was faster (t (1/2) = 6.7 h) than in normal subjects (t (1/2) = 12 ± 0.7 h). FVIII‐VWF interaction, A Disintegrin And Metalloprotease with ThromboSpondin type 1 motif‐13 levels, ristocetin‐induced‐platelet‐aggregation, and VWF multimeric pattern were normal. The p.P1127S variant was normally synthesized and secreted by HEK‐293 cells, and molecular modeling predicts a conformational change showing higher affinity for the macrophagic scavenger receptor lipoprotein receptor‐related protein 1 (LRP1), as also experimentally verified. CONCLUSIONS: The p.P1127S variant may cause a low VWF phenotype, stemming from an increased VWF affinity for the scavenger receptor LRP1 and, consequently, an accelerated clearance of VWF. John Wiley and Sons Inc. 2022-06-09 2022-08 /pmc/articles/PMC9545986/ /pubmed/35596664 http://dx.doi.org/10.1111/jth.15765 Text en © 2022 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle HAEMOSTASIS
Sacco, Monica
Lancellotti, Stefano
Branchini, Alessio
Tardugno, Maira
Testa, Maria Francesca
Lunghi, Barbara
Bernardi, Francesco
Pinotti, Mirko
Giusti, Betti
Castaman, Giancarlo
De Cristofaro, Raimondo
The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms
title The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms
title_full The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms
title_fullStr The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms
title_full_unstemmed The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms
title_short The p.P1127S pathogenic variant lowers von Willebrand factor levels through higher affinity for the macrophagic scavenger receptor LRP1: Clinical phenotype and pathogenic mechanisms
title_sort p.p1127s pathogenic variant lowers von willebrand factor levels through higher affinity for the macrophagic scavenger receptor lrp1: clinical phenotype and pathogenic mechanisms
topic HAEMOSTASIS
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545986/
https://www.ncbi.nlm.nih.gov/pubmed/35596664
http://dx.doi.org/10.1111/jth.15765
work_keys_str_mv AT saccomonica thepp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms
AT lancellottistefano thepp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms
AT branchinialessio thepp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms
AT tardugnomaira thepp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms
AT testamariafrancesca thepp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms
AT lunghibarbara thepp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms
AT bernardifrancesco thepp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms
AT pinottimirko thepp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms
AT giustibetti thepp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms
AT castamangiancarlo thepp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms
AT decristofaroraimondo thepp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms
AT saccomonica pp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms
AT lancellottistefano pp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms
AT branchinialessio pp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms
AT tardugnomaira pp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms
AT testamariafrancesca pp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms
AT lunghibarbara pp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms
AT bernardifrancesco pp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms
AT pinottimirko pp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms
AT giustibetti pp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms
AT castamangiancarlo pp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms
AT decristofaroraimondo pp1127spathogenicvariantlowersvonwillebrandfactorlevelsthroughhigheraffinityforthemacrophagicscavengerreceptorlrp1clinicalphenotypeandpathogenicmechanisms